Cargando…
Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis: A Dose-Ranging Study
OBJECTIVE: Metronidazole vaginal gel (MVG) 0.75% is a US Food and Drug Administration–approved, 5-day treatment for bacterial vaginosis (BV). This study tested the hypothesis that a shorter treatment course at a higher dose (MVG 1.3%) would yield similar efficacy to 5 days of MVG 0.75%. MATERIALS AN...
Autores principales: | Chavoustie, Steven E., Jacobs, Mark, Reisman, Howard A., Waldbaum, Arthur S., Levy, Sharon F., Hillier, Sharon L., Nyirjesy, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376277/ https://www.ncbi.nlm.nih.gov/pubmed/24983350 http://dx.doi.org/10.1097/LGT.0000000000000062 |
Ejemplares similares
-
Enfermedades benignas de la vulva y la vagina /
Publicado: (1996) -
Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3)
por: Madeleine, Margaret M., et al.
Publicado: (2016) -
Development of the Adult Vulvar Lichen Sclerosus Severity Scale—A Delphi Consensus Exercise for Item Generation
por: Sheinis, Michal, et al.
Publicado: (2018) -
Is Vulvovaginal Lichen Planus Associated With Squamous Cell Carcinoma?
por: Day, Tania, et al.
Publicado: (2018) -
Classic and Hypertrophic Vulvar Lichen Planus
por: Day, Tania, et al.
Publicado: (2018)